Sequence to Solution: Synthetic DNA Accelerating Advanced Therapies

Watch our on-demand Webinar

Discover how synthetic DNA is transforming advanced therapies, enabling faster development of personalized cancer vaccines and mRNA treatments from sequence to clinic.

Bringing together two pioneering companies, Neomatrix Biotech and HelixNano, this webinar features insights from Luigi Aurisicchio, CEO, and Marianna Keaveney, CSO, as they share how synthetic DNA is powering their development pipelines and accelerating therapeutic innovation.

You’ll learn:

• How synthetic DNA accelerates development timelines for personalized cancer vaccines and mRNA-based therapies

• The importance of DNA quality, sequence accuracy, and customization for successful clinical translation

• Real-world case studies demonstrating how development bottlenecks were overcome

• Key technical advantages, including construct design flexibility, speed, and scalability